Clinical application of Lishengsu for treatment of leukopenia induced by chemotherapy / 中国实验血液学杂志
Journal of Experimental Hematology
;
(6): 96-98, 2003.
Artigo
em Chinês
| WPRIM
| ID: wpr-355707
ABSTRACT
The efficacy and safety of Lishengsu (a rhG-CSF preparation) were evaluated for treatment of chemotherapy-induced leukopenia. 327 cases of leukopenia with grade I-IV induced by chemotherapy were subcutaneously administered at 2.5 - 5.0 micro g/(kg x d) of Lishengsu, and hemogram and the side effects were observed. The results showed that Lishengsu had satisfactory effect to cure leukopenia after chemtherapy, with an effective rate of 99.4% (325/327), the side effects were quite slight. It is concluded that Lishengsu is efficient and safe for patients with leukopenia, and can be used as an adjuvant drug for treatment of leukopenia after chemotherapy.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Assunto principal:
Contagem de Plaquetas
/
Sangue
/
Proteínas Recombinantes
/
Hemoglobinas
/
Fator Estimulador de Colônias de Granulócitos
/
Resultado do Tratamento
/
Usos Terapêuticos
/
Tratamento Farmacológico
/
Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos
/
Contagem de Leucócitos
Limite:
Adolescente
/
Adulto
/
Idoso
/
Feminino
/
Humanos
/
Masculino
Idioma:
Chinês
Revista:
Journal of Experimental Hematology
Ano de publicação:
2003
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS